M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine, talks about the services federally qualified centers provide, specifically how they help patients access medications.
M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine, talks about the services federally qualified centers provide, specifically how they help patients access medications.
Transcript
What services do federally qualified health centers provide, and how do they help patients access prescription medicines?
They started out as a primary care safety net but they do take a nice holistic approach and branch out quickly into mental health services and dentistry and various health centers can specialize in with different service provision based on their patient population.
Another really cool fact about health centers is that about 51% of their governing body has to be patients and it has to be representative of the patient population that they serve. Which they take inventory with every year when they submit their grade report to HRSA [Health Resources and Services Administration]. They see who they are serving and see what their needs are and that has to get evaluated by their board. So, it’s really quite unique Every health center is a little bit different because they are serving patients based off that need and the agency that those patients have sitting on a governing body and telling the health center leadership what they need. They wind up looking a little different.
And how the 2 venues that we found for my research and how they provide access to prescription medications for uninsured people, specifically is the HRSA 340B program, which gets discounted drugs at a price by contacting HRSA for patients at health centers, as well as disproportionate share hospitals. We focus on the health centers, the primary care access, for either retail pharmacies or direct service provision health center can run a pharmacy itself. So, it’s especially more helpful in rural areas for a patient that is unable to access even a Walgreens.
Then also there’s the drug assistance programs which are the health centers have become very adept at utilizing the discounted drugs and free drugs that the pharmaceutical company manufacturers may provide directly to as kind of a good service to the world that they apply for and dual eligibility assistance for their patients and get access that way if they don’t have access through their insurance or through 340b program. So, both methods at the same time usually is what we found.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More